Related Experiment Video
Updated: Aug 31, 2026

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
Various effects of paromomycin on tmRNA-mediated trans-translation
Takayuki Konno1, Toshiharu Takahashi, Akira Muto
1Department of Biochemistry and Biotechnology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki 036-8561, Japan.
Abstract:
Trans-translation is an unusual translation in which tmRNA plays a dual function as a tRNA and an mRNA to relieve the stalled translation on the ribosome. In this study, we examined the effects of an aminoglycoside antibiotic, paromomycin, on several tmRNA-related events in vitro. A chemical footprinting study revealed that paromomycins bind tmRNA in the tRNA domain and in the middle of the long helix between tRNA and mRNA domains. Paromomycin bound in the tRNA domain inhibited aminoacylation, and the inhibition was suppressed by the addition of SmpB, a tmRNA binding protein. It was also found that paromomycin causes a shift of the translation-resuming point on tmRNA by -1. The effect on initiation-shift was canceled by a mutation at the paromomycin binding site in 16S rRNA, but not by mutations in tmRNA. The effect of paromomycin on trans-translation differs substantially from that on canonical translation, in which it induces miscoding by modulating the A site of the decoding helix of the small subunit RNA of the ribosome.
Insights
Paromomycin antibiotic affects bacterial trans-translation by binding tmRNA, inhibiting its function. This binding alters translation resumption and differs from paromomycin's effect on standard protein synthesis.
Area of Science:
- Molecular Biology
- Microbiology
- Biochemistry
Background:
- Trans-translation is a unique cellular mechanism essential for rescuing stalled ribosomes.
- tmRNA (transfer-messenger RNA) acts as both tRNA and mRNA, facilitating the release of stalled polypeptide chains.
- Aminoglycoside antibiotics like paromomycin are known to interfere with bacterial translation.
Purpose of the Study:
- To investigate the in vitro effects of paromomycin on tmRNA-mediated trans-translation.
- To identify specific binding sites of paromomycin on tmRNA.
- To elucidate the impact of paromomycin binding on key trans-translation events.
Main Methods:
- Chemical footprinting to map paromomycin binding sites on tmRNA.
- In vitro assays to assess the effects of paromomycin on tmRNA aminoacylation.
- Analysis of translation resumption point shifts induced by paromomycin.
- Site-directed mutagenesis of 16S rRNA and tmRNA to identify resistance mutations.
Main Results:
- Paromomycin binds to tmRNA in both the tRNA domain and the helix connecting tRNA and mRNA domains.
- Binding in the tRNA domain inhibits aminoacylation, an effect partially rescued by SmpB protein.
- Paromomycin induces a -1 shift in the translation resumption point on tmRNA.
- This shift is dependent on the 16S rRNA binding site but not tmRNA sequence variations.
Conclusions:
- Paromomycin directly interferes with tmRNA function through specific binding.
- The antibiotic's mechanism against trans-translation is distinct from its action on canonical translation.
- Understanding these interactions could inform the development of new antibiotics targeting bacterial protein synthesis.
Related Concept Videos
Translation
Translation
Leaky Scanning
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
MicroRNAs
MicroRNAs

